A detailed history of Group One Trading, L.P. transactions in Aldeyra Therapeutics, Inc. stock. As of the latest transaction made, Group One Trading, L.P. holds 1,846 shares of ALDX stock, worth $10,134. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,846
Previous 6,046 69.47%
Holding current value
$10,134
Previous $19,000 68.42%
% of portfolio
0.0%
Previous 0.0%

Shares

24 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$3.25 - $4.72 $13,650 - $19,824
-4,200 Reduced 69.47%
1,846 $6,000
Q1 2024

May 10, 2024

SELL
$2.77 - $4.22 $19,276 - $29,366
-6,959 Reduced 53.51%
6,046 $19,000
Q4 2023

Feb 14, 2024

SELL
$1.47 - $6.06 $77,235 - $318,398
-52,541 Reduced 80.16%
13,005 $45,000
Q3 2023

Nov 09, 2023

BUY
$6.11 - $8.16 $400,486 - $534,855
65,546 New
65,546 $437,000
Q1 2023

May 12, 2023

BUY
$5.77 - $9.93 $497,904 - $856,879
86,292 Added 590.35%
100,909 $1 Million
Q4 2022

Feb 09, 2023

SELL
$5.08 - $7.09 $57,383 - $80,088
-11,296 Reduced 43.59%
14,617 $101,000
Q3 2022

Nov 09, 2022

BUY
$3.8 - $7.74 $9,868 - $20,100
2,597 Added 11.14%
25,913 $138,000
Q2 2022

Aug 11, 2022

SELL
$2.43 - $4.85 $120,897 - $241,297
-49,752 Reduced 68.09%
23,316 $93,000
Q1 2022

May 12, 2022

SELL
$3.25 - $5.17 $18,850 - $29,986
-5,800 Reduced 7.35%
73,068 $325,000
Q4 2021

Feb 11, 2022

SELL
$3.5 - $9.63 $8,585 - $23,622
-2,453 Reduced 3.02%
78,868 $315,000
Q3 2021

Nov 12, 2021

BUY
$7.94 - $11.31 $645,688 - $919,740
81,321 New
81,321 $714,000
Q2 2021

Aug 10, 2021

SELL
$10.44 - $14.85 $632,173 - $899,212
-60,553 Closed
0 $0
Q1 2021

May 12, 2021

BUY
$6.53 - $14.42 $395,411 - $873,174
60,553 New
60,553 $719,000
Q4 2020

Feb 10, 2021

SELL
$6.31 - $8.13 $152,462 - $196,437
-24,162 Closed
0 $0
Q3 2020

Nov 12, 2020

BUY
$4.0 - $7.53 $57,660 - $108,544
14,415 Added 147.89%
24,162 $179,000
Q2 2020

Aug 13, 2020

BUY
$1.97 - $5.05 $5,210 - $13,357
2,645 Added 37.24%
9,747 $41,000
Q1 2020

May 13, 2020

SELL
$1.62 - $6.4 $6,598 - $26,067
-4,073 Reduced 36.45%
7,102 $18,000
Q4 2019

Feb 10, 2020

BUY
$4.73 - $7.98 $23,233 - $39,197
4,912 Added 78.43%
11,175 $65,000
Q3 2019

Nov 12, 2019

SELL
$4.41 - $6.12 $40,572 - $56,304
-9,200 Reduced 59.5%
6,263 $33,000
Q2 2019

Aug 09, 2019

SELL
$6.0 - $9.0 $72,552 - $108,828
-12,092 Reduced 43.88%
15,463 $93,000
Q1 2019

May 13, 2019

BUY
$7.14 - $9.85 $196,742 - $271,416
27,555 New
27,555 $249,000
Q4 2018

Feb 06, 2019

SELL
$7.26 - $13.29 $3,317 - $6,073
-457 Closed
0 $0
Q3 2018

Nov 08, 2018

SELL
$6.8 - $14.35 $1,652 - $3,487
-243 Reduced 34.71%
457 $6,000
Q2 2018

Aug 14, 2018

BUY
$6.95 - $9.18 $4,865 - $6,426
700 New
700 $6,000

Others Institutions Holding ALDX

About Aldeyra Therapeutics, Inc.


  • Ticker ALDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 58,323,100
  • Market Cap $320M
  • Description
  • Aldeyra Therapeutics, Inc., a biotechnology company, develops and commercializes medicines for immune-mediated ocular and systemic diseases. The company's lead product candidate is reproxalap, a reactive aldehyde species (RASP)modulator, which is in Phase III clinical trial for the treatment of dry eye diseases and allergic conjunctivitis. It al...
More about ALDX
Track This Portfolio

Track Group One Trading, L.P. Portfolio

Follow Group One Trading, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Group One Trading, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Group One Trading, L.P. with notifications on news.